Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...
The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...
Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...
As artificial intelligence (AI) continues to develop at a rapid pace, even the most sophisticated general counsel (GC) and in-house legal teams ...
Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug ...
Chemistry labs are also making effective use of AI. Repetitive and time-consuming laboratory tasks are now being performed by ...
Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.
Despite major advances in artificial intelligence (AI) research for healthcare, the deployment and adoption of AI technologies remain limited in clinical practice. This paper describes the FUTURE-AI ...
AI’s role in healthcare evolved significantly in 2024. Rather than generic AI solutions, startups focused on specialized, ...
WVU has formed a strategic partnership with GATC Health Corp, a tech-bio company that uses artificial intelligence to ...
Explore the distinctions between Generative AI and Agentic AI. Understand how each works, their use cases, limitations, and ...
By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.